Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Probuphine
    • Ropinirole Implant
    • T3 Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Company Information
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Titan FCOI Policy
    • Financial Info
    • Financials
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
  • Search

Press Releases

  • Home
  • Investors
  • News / Events
  • Press Releases
Investors

Navigate Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Announces Third Quarter 2013 Financial Results

November 14, 2013

Titan Pharmaceuticals Announces $5 Million Equity Investment and Restructuring of Probuphine Partnership

November 13, 2013

Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2013 Financial Results

November 8, 2013

Titan Pharmaceuticals Announces Confirmation of Meeting With FDA Regarding Probuphine

September 26, 2013

Titan Pharmaceuticals Announces Submission of FDA Meeting Request Regarding Probuphine

September 4, 2013

Titan Pharmaceuticals Announces Second Quarter 2013 Financial Results

August 14, 2013

Titan Pharmaceuticals Announces Publication of Phase 3 Probuphine Data in Addiction

August 13, 2013

Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2013 Financial Results

August 8, 2013

Titan Pharmaceuticals Announces Amendment to Partnership With Braeburn Pharmaceuticals

May 29, 2013

Titan Pharmaceuticals Announces First Quarter 2013 Financial Results

May 16, 2013

RSS
  • « Previous
  • 1...
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • ...23
  • Next »
© 2021 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap